OABI Q4 2023 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-86.4% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$21M-439.8% margin

Net Income

-$14M-291.4% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-12.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$375M

Total Liabilities

$61M

Stockholders' Equity

$315M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$35M	-86.4%
Gross Profit	$5M	$32M	-85.0%
Operating Income	-$21M	$9M	-337.1%
Net Income	-$14M	$7M	-306.1%

Revenue Segments

Service

$9M92%

Royalty

$834,0008%